We are live on ! Find out more
CM

Corvex Management Portfolio holdings

AUM $2.52B
1-Year Est. Return 25.53%
This Fund
S&P 500
This Quarter Est. Return
+20.41%
1 Year Est. Return
+25.53%
3 Year Est. Return
+64.15%
5 Year Est. Return
+76.52%
10 Year Est. Return
+305.53%
AUM
$8.43B
AUM Growth
+$1.3B
Cap. Flow
+$174M
Cap. Flow %
2.07%
Top 10 Hldgs %
67.74%
Holding
70
New
13
Increased
13
Reduced
9
Closed
26

Top Buys

Rank Stock Value
1
MON
Monsanto Co
MON
+$352M
2
ICE icon
Intercontinental Exchange
ICE
+$233M
3
LAMR icon
Lamar Advertising Co
LAMR
+$112M
4
APC
Anadarko Petroleum
APC
+$94.2M
5
AGN
Allergan plc
AGN
+$91.4M

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$293M
2
AMT icon
American Tower
AMT
+$172M
3
LVLT
Level 3 Communications Inc
LVLT
+$141M
4
DHR icon
Danaher
DHR
+$129M
5
HCA icon
HCA Healthcare
HCA
+$116M

Sector Composition

Rank Sector Weight
1 Energy 28.8%
2 Financials 9.79%
3 Healthcare 8.01%
4 Real Estate 8.01%
5 Consumer Discretionary 7.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GM icon
51
CALL
General Motors
GM
$79.5B
– –
-1,500,000
Closed -$51.6M
PPLI
52
People Inc
PPLI
$3.02B
– –
-5,512,036
Closed -$70.3M
KR icon
53
CALL
Kroger
KR
$35.5B
– –
-1,000,000
Closed -$21.8M
LAMR icon
54
CALL
Lamar Advertising Co
LAMR
$16.1B
– –
-500,000
Closed -$25.5M
LAMR icon
55
PUT
Lamar Advertising Co
LAMR
$16.1B
– –
-1,250,000
Closed -$63.7M
MSGS icon
56
Madison Square Garden
MSGS
$9.53B
– –
-1,128,349
Closed -$45.7M
PEP icon
57
PepsiCo
PEP
$190B
– –
-747,600
Closed -$62.4M
PSX icon
58
Phillips 66
PSX
$84.1B
– –
-199,998
Closed -$15.4M
TEVA icon
59
CALL
Teva Pharmaceuticals
TEVA
$40.6B
– –
-500,000
Closed -$26.4M
TMO icon
60
CALL
Thermo Fisher Scientific
TMO
$210B
– –
-500,000
Closed -$60.1M
TMO icon
61
Thermo Fisher Scientific
TMO
$210B
– –
-2,439,794
Closed -$293M
VTRS icon
62
CALL
Viatris
VTRS
$20.4B
– –
-600,000
Closed -$29.3M
VTRS icon
63
Viatris
VTRS
$20.4B
– –
-659,500
Closed -$32.2M
VIAB
64
DELISTED
Viacom Inc. Class B
VIAB
– –
-1,240,008
Closed -$105M
NSM
65
DELISTED
Nationstar Mortgage Holdings
NSM
– –
-108,468
Closed -$3.6M
FDO
66
PUT
DELISTED
FAMILY DOLLAR STORES
FDO
– –
-584,700
Closed -$33.9M
ZLC
67
DELISTED
ZALE CORPORATION
ZLC
– –
-1,573,594
Closed -$32.9M
LPNT
68
DELISTED
LifePoint Health, Inc.
LPNT
– –
-154,759
Closed -$8.44M
TWC
69
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
– –
-100,000
Closed -$13.7M
AGN
70
CALL
DELISTED
Allergan Inc
AGN
– –
-900,000
Closed -$112M
1 2
3

Similar funds

LIMS
Lasalle Investment Management Securities Baltimore, Maryland $2.53B AUM 2.06% 1-Year Est. Return
SIM
Stratos Investment Management Beachwood, Ohio $2.49B AUM 17.24% 1-Year Est. Return
KFC
Klingenstein Fields & Co New York $2.54B AUM 22.19% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
Q
QVR San Francisco, California $2.49B AUM 48.58% 1-Year Est. Return
LC
L1 Capital Melbourne VIC 3000, Australia $2.55B AUM 80.12% 1-Year Est. Return
FFA
First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return
BL
Balentine LLC Atlanta, Georgia $2.48B AUM 17.44% 1-Year Est. Return

Corvex Management's Q2 2014 Portfolio in Review

As of Q2 2014, Corvex Management held 70 positions worth $8.43B, up 18% from $7.13B the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Corvex Management's Q2 2014 filing shows 13 new, 13 increased, 9 reduced and 26 closed positions. Its largest new stake was Intercontinental Exchange: 5,981,065 shares worth $226M. The largest sale was Thermo Fisher Scientific, an estimated $293M.

By sector, the portfolio is most concentrated in Energy at 29% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

  • Corvex Management's largest Q2 2014 buy was Intercontinental Exchange: 5,981,065 shares worth $226M.
  • Corvex Management added most to Monsanto Co in Q2 2014, an estimated $352M increase.
  • Corvex Management's biggest Q2 2014 reduction was Level 3 Communications Inc, cutting an estimated $141M.
  • Corvex Management fully exited Thermo Fisher Scientific in Q2 2014, selling an estimated $293M.
  • Corvex Management's ten largest holdings make up 68% of its $8.43B portfolio in Q2 2014.
  • Corvex Management opened 13 new positions and closed 26 in Q2 2014.
  • Corvex Management's portfolio value rose 18% quarter-over-quarter to $8.43B.

Based on Corvex Management's 13F filing for Q2 2014, filed 14 Aug 2014.